Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis, **Tylenol, Autism and Vaccines: What to Know After Trump’s Announcement, and F.D.A. to Relabel Leucovorin for Autism Treatment** highlight ongoing discussions and controversies surrounding autism, from unproven links to Tylenol to new FDA actions on potential treatments.

• Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis — The New York Times Science -
• Tylenol, Autism and Vaccines: What to Know After Trump’s Announcement — The New York Times Science -
• F.D.A. to Relabel Leucovorin for Autism Treatment — The New York Times Science -

Judge Says Work on Revolution Wind Can Proceed, for Now and Sunday Was Also Sun Day show progress and advocacy in renewable energy, despite political hurdles.

• Judge Says Work on Revolution Wind Can Proceed, for Now — The New York Times Science -
• Sunday Was Also Sun Day — The New York Times Science -

A Maternity Ward in Chad Reaches Its Breaking Point as U.S. Aid Dries Up underscores the severe impact of diminishing international aid on vulnerable populations.

• A Maternity Ward in Chad Reaches Its Breaking Point as U.S. Aid Dries Up — The New York Times Science -

The passing of Louise Vincent, 49, Drug User Who Led Harm Reduction Movement, Dies marks the loss of a key figure in advocating for safer drug use practices.

• Louise Vincent, 49, Drug User Who Led Harm Reduction Movement, Dies — The New York Times Science -

NASA Picks 10 New Astronauts as Focus Shifts to the Moon and Mars heralds a new era for space exploration with a fresh cohort of astronauts eyeing lunar and Martian missions.

• NASA Picks 10 New Astronauts as Focus Shifts to the Moon and Mars — The New York Times Science -

**Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growth** reveals the significant economic ripple effects stemming from a major pharmaceutical company's challenges.

• Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growth — The New York Times Science -